Search Tag: alteplase
2018 30 Jan
Cancer patients having a stroke are one-third less likely than stroke patients without cancer to get a gold-standard drug to help dissolve the clot, according to results of a study presented at the American Stroke Association’s International Stroke Conference in Los Angeles. Strokes in cancer patients can be caused by traditional risk factors such...Read more
2014 25 Aug
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) is currently reviewing the safety of alteplase, a clot-busting drug. The drug is to be reviewed for the treatment of strokes. The regulatory agency believes that the benefits of alteplase outweigh its risks but because there is a chance that some previous assessments may have been flawed,...Read more